Skip to main content
Haemato AG logo

Haemato AG — Investor Relations & Filings

Ticker · HAEK ISIN · DE000A289VV1 LEI · 529900Q3CGRYVCW7E340 F Wholesale and retail trade
Open in API
Filings indexed 188 across all filing types
Latest filing 2023-05-31 Earnings Release
Country DE Germany
Listing F HAEK

About Haemato AG

https://haemato.de/en/start.html

Haemato AG is a pharmaceutical company focused on the specialty pharma market, concentrating on treatments for chronic diseases and high-priced therapies. The company's business activities include the development, acquisition, licensing, and distribution of a product portfolio that comprises innovative patent-protected medicines, biosimilars, and generics. The portfolio also extends to narcotics, including cannabis products, as well as over-the-counter (OTC) products and special cosmetics. Haemato AG's primary therapeutic areas of focus are HIV/AIDS, neurology, oncology, rheumatology, and ophthalmology.

Recent filings

Filing Released Lang Actions
HAEMATO AG with a strong start into the year 2023: Revenue increase of over 25% compared to the same quarter of the previous year and disproportionate increase in the operating result
Earnings Release Classification · 100% confidence The document is titled with a date and highlights key financial metrics for the first quarter of 2023 (Q1 2023), explicitly mentioning 'Quarterly / Interim Statement' as a keyword. It details revenue, EBITDA, and EBIT for the period, which is characteristic of an earnings release or an interim report. Since it provides the key financial highlights immediately upon release, it fits the definition of an Earnings Release (ER). Although it mentions the Annual Report was published previously and proposes a dividend for the AGM, the primary focus and content structure are that of a quarterly financial update announcement. Given the options, ER is the most appropriate classification for this initial release of quarterly results. Q1 2023
2023-05-31 English
HAEMATO AG: Dividend of EUR 1.20
Notice of Dividend Amount Classification · 100% confidence The document is a short news release dated May 16, 2023, announcing that the Executive Board and Supervisory Board will propose a dividend of EUR 1.20 per share to the upcoming Annual General Meeting (AGM) on July 18, 2023. The primary focus is the declaration of a specific dividend amount. This directly corresponds to the definition for 'Notice of Dividend Amount' (DIV). Although it mentions the AGM, the core information is the dividend proposal, not the AGM materials themselves (AGM-R) or the full financial results (10-K/IR). Since the document is short and serves as an announcement, DIV is the most precise classification.
2023-05-16 English
HAEMATO AG publishes preliminary figures for the 2022 financial year: Strong increase in net profit and operating cash flow
Earnings Release Classification · 100% confidence The document is titled "HAEMATO AG publishes preliminary figures for the 2022 financial year: Strong increase in net profit and operating cash flow" and explicitly states it contains "preliminary IFRS financial statements" for the full 2022 financial year. It details key financial metrics like revenue, net income, EBIT, and equity ratio for the year ended 2022, and provides guidance for 2023. This content structure strongly indicates an Earnings Release (ER), which is the initial announcement of periodical financial results, often containing preliminary figures before the full 10-K is filed. It is not the comprehensive Annual Report (10-K) itself, nor is it a transcript (CT) or a formal Audit Report (AR). Since it announces preliminary results for a full year, ER is the most appropriate classification over IR (Interim Report). FY 2022
2023-04-13 English
Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Audit Report / Information Classification · 98% confidence The document is titled 'Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021' (Consolidated Financial Statements for the fiscal year from 01.01.2021 to 31.12.2021) and contains extensive sections like '4. KONZERNLAGEBERICHT' (Group Management Report), detailed discussions on the economic environment ('Wirtschaftsbericht'), and specific financial performance metrics (e.g., 'Der Konzernumsatz stieg im Jahr 2021 auf EUR 285,04 Mio.'). This structure, covering a full fiscal year and including a management report, strongly indicates a comprehensive annual financial filing. Although the text is in German, the content aligns perfectly with the scope of a 10-K (Annual Report), which is the standard comprehensive yearly report. Given the length (159,269 chars) and the detailed nature of the content, it is the report itself, not just an announcement (RPA/RNS). FY 2021
2023-02-14 German
HAEMATO AG: publishes figures for the 3rd quarter 2022
Earnings Release Classification · 100% confidence The document is titled "HAEMATO AG: publishes figures for the 3rd quarter 2022" and contains key financial metrics for the first nine months and the third quarter of 2022 (e.g., revenue, EBIT, equity ratio). It explicitly mentions publishing figures for a period shorter than a year (Q3 and 9 months). This content aligns perfectly with the definition of an Interim / Quarterly Report (IR). It is not a full Annual Report (10-K), nor is it just a brief announcement of a report's publication (RPA), as it contains substantial financial details. It is also more comprehensive than a simple Earnings Release (ER) which usually contains only highlights. 9M 2022
2022-11-14 English
Half-yearly financial statements 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM REPORT 2022' and contains comprehensive financial data, including a consolidated profit and loss account, balance sheet, cash flow statement, and management discussion for the first half of the year (01.01. - 30.06.2022). It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2022
2022-10-07 English

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.